The Annual Meeting of

Take Part in Antibody Engineering & Therapeutics 2013

• Attend - Register Now and Save up to $550
• Present a Poster - Submit an abstract; Get faster approval to attend
• Sponsor/Exhibit

Stay Connected

Join IBC Life Sciences' LinkedIn group: Antibody & Protein Therapeutics - From Discovery to Production

Follow @ibcusa and #antibodyeng on Twitter for special offers and news about the event.

Connect on Facebook

Add the event to your calendar by selecting "Join" on the event page

Get Up-to-Date Event Information

Join our priority contact list and receive the latest event news.

Attendee Testimonials

See what our 2012 attendees had to say about their experience
» Read testimonials

Huntington Beach Location!

Huntington Beach, CA is conveniently located to 3 airports: Los Angeles (LAX), Orange County (SNA) and Long Beach (LGB)

» Travel tips/information

Learn New Approaches to Your Research Programs

View a full list of the scientific poster presentations that were on display at Antibody Engineering and Antibody Therapeutics 2012.

See the Event Guide from 2012

Download the 2012 onsite event guide to see the caliber of presentations

Supporting the Scientific Community in Development Therapeutic Antibodies for Over 2 Decades

Announcing IBC's Antibody Engineering & Therapeutics, just for 2013, is moving to a refreshing new beachfront location in Huntington Beach, CA. This gorgeous venue is easily accessible by Los Angeles (LAX), Orange County (SNA) and Long Beach (LGB) airports! Join us December 8-12, 2013 at the world's leading forum for the exchange of cutting-edge protein engineering science and antibody therapeutics now in development.

» We are now accepting speaker proposals for 2013 - submit your topic idea today!

Just Announced:
Early Confirmed Keynote Speakers

Leroy Hood, M.D., Ph.D.
President
Institute for Systems Biology

Merging Science with Technology to Accelerate Antibodies to Market...

Now in its 24th year, Antibody Engineering & Therapeutics has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Our attendees come back year after year for the information they need to stay abreast of the latest scientific trends in the antibody field. World-renowned scientists from across the globe convene at this event to share best practices and new approaches to exploit antibodies for developing novel medicines and vaccines. Learn about both the basic science of antibody engineering and the latest preclinical/clinical data, including safety and efficacy studies of the most cutting-edge antibody therapeutics now in development. We hope to see you this December in Huntington Beach!

2012 Conference Meeting Summary

Looking Into Antibody Engineering & Therapeutics 2013

Here is a Sneak Peek at Some of the Exciting New Topics to be Covered:

• Systems biology/systems immunology of antibodies - how is everything connected?
• Alternative antibody formats: Mixtures, oligoclonals and polyclonals
• Anatomy/physiology of antibody distribution in different biological systems
• Intracellular antibodies
• Antibody library design and affinity maturation techniques
• Deep-sequencing of antibody responses
• Linkers and conjugation strategies for antibodies
• Immunomodulatory antibodies for cancer therapy and other diseases
• Non-cancer antibodies: infectious disease, non-malignant disease, autoimmune, CNS
• Clinical successes and failures - what have we learned?
• Antibody effector function
• Immunogenicity
• Antibodies as probes for intracellular post-translational modifications
• Cell biology of membranes, receptors and signaling leading to new targets for antibodies
• The Interface between humoral and cell-mediated immunity in cancer
• Non-antibody scaffolds
• Tumor targeting strategies: Why does so little antibody get into the tumor? How to improve?
• Physiology of tissue degradation
• Dealing with off target toxicity and PK/PD of proteins
• Clinical design strategies for antibody drugs, including phase 1 and phase 0 trial design
• Biomarkers, imaging and companion diagnostics for antibody drugs
• Building in manufacturability to your antibodies, optimization techniques for production
• Patient enrichment strategies for mAb therapies
• Antibodies by design: bioinformatics and modeling strategies to develop target-biased libraries
• Molecular engineering and design strategies
• Antibody administration: local and targeted delivery, alternative delivery approaches
• Gene-based Ab Expression - the intersection of Abs and gene therapy
• Antibodies in a complex environment
• From receptor biology to therapy
• Antibody-drug conjugates: preclinical and clinical updates
• Alternative antibody scaffolds, multifunctional antibodies, bispecifics, combinations
• Antibody activity and animal models
• Modulating half-life of antibody therapeutics
• Development status of early stage therapeutic antibodies
• Diagnostic applications of antibodies